12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joel Trugman, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
138 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Synexus Clinical Research Us, Inc.
Chandler, Arizona, United States
- Advanced Research Associates
Glendale, Arizona, United States
- Alea Research Institute
Phoenix, Arizona, United States
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Orange Grove Family Practice
Tucson, Arizona, United States
- Principals Research Group
Hot Springs, Arkansas, United States
- Arkansas Clinical Research
Little Rock, Arkansas, United States
- Baptist Health Center for Clinical Research
Little Rock, Arkansas, United States
- Med Center Medical Clinic
Carmichael, California, United States
- Triwest Research Associates
El Cajon, California, United States
- California Headache and Balance Center
Fresno, California, United States
- Neuro Pain Medical Center
Fresno, California, United States
- Fullerton Neurology and Headache Center
Fullerton, California, United States
- Neurology Center of North Orange County
Fullerton, California, United States
- Nervepro Research Bruce Cleeremans
Irvine, California, United States
- Grossmont Center for Clinical Research
La Mesa, California, United States
- Torrance Clinical Research Institute, Inc.
Lomita, California, United States
- Long Beach Clinical Trials Services
Long Beach, California, United States
- Keck Medicine of Usc
Los Angeles, California, United States
- Newport Beach Clinical Research Associates
Newport Beach, California, United States
- Pharmacology Research Institute
Newport Beach, California, United States
- Excell Research, Inc.
Oceanside, California, United States
- Stanford
Palo Alto, California, United States
- Rancho Cucamonga Clinical Research
Rancho Cucamonga, California, United States
- Desert Valley Research
Redlands, California, United States
- George J. Rederich, M.D. Inc.
Redondo Beach, California, United States
- Paradigm Clinical Research Centers, Inc
San Diego, California, United States
- Optimus Medical Group
San Francisco, California, United States
- California Neuroscience Research
Sherman Oaks, California, United States
- Synexus Clinical Research Us, Inc.
Vista, California, United States
- Colorado Springs Neurological Associates
Colorado Springs, Colorado, United States
- Delta Waves, Inc.
Colorado Springs, Colorado, United States
- Colorado Neurological Institute
Englewood, Colorado, United States
- New England Institute for Clinical Research
Stamford, Connecticut, United States
- Aventura Neurological Associates
Aventura, Florida, United States
- Neurology Offices of South Florida
Boca Raton, Florida, United States
- Sarkis Clinical Trials- Gainesville
Gainesville, Florida, United States
- Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
- Westside Center for Clinical Research
Jacksonville, Florida, United States
- Neurology Associates, P.A.
Maitland, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Dec 2018
- Primary completion
- 19 Jun 2020
- Completion
- 19 Jun 2020
- Last update posted
- 9 Jul 2021
- Registered enrollment
- 910
- Registry id
- NCT03777059
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.